Article

Age Dependent Reduction of Neutralization Capacities Against Delta Variant Five Months Post-Vaccination (BNT162b2)

2021-10-21

Abstract excerpt

Background: Long-term control of SARS-CoV-2 via vaccination has been confounded by the introduction of the Delta variant (B1.617.2). Herein, we assessed Delta variant-specific effectiveness of BNT162b2 and characterize Delta-driven breakthrough COVID-19 cases with known-time-since-vaccination.<br><br>Methods: In this longitudinal, prospective study (January 21 to September 01 2021), we obtained samples from naïve...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9bef301c-01ec-589b-b603-4537b231e799
DOI: 10.2139/ssrn.3943134

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Age Dependent Reduction of Neutralization Capacities Against Delta Variant Five Months Post-Vaccination (BNT162b2)DOI 10.2139/ssrn.3943134Read

Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpointSemantic proximity Read

BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other VariantsSemantic proximity Read

Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccineSemantic proximity Read

BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in QatarSemantic proximity Read

High seroconversion rate and SARS-CoV-2 Delta neutralization in PLWHIV vaccinated with BNT162b2Semantic proximity Read

Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated IndividualsSemantic proximity Read

Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responsesSemantic proximity Read

Immunogenicity of a BNT162b2 Vaccine Booster Against SARS-CoV-2 Delta and Omicron Variants in Older PeopleSemantic proximity Read

Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in QatarSemantic proximity Read

SARS-CoV-2 evolved during advanced HIV disease immunosuppression has Beta-like escape of vaccine and Delta infection elicited immunitySemantic proximity Read

BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19Semantic proximity Read

Slow waning of antibodies following a third dose of BNT162b2 in adults who had previously received two doses of inactivated vaccineSemantic proximity Read